Drug
ACEI
ACEI is a pharmaceutical drug with 6 clinical trials. Currently 1 active trials ongoing. Historical success rate of 50.0%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
50.0%
Based on 2 completed trials
Completion Rate
50%(2/4)
Active Trials
1(17%)
Results Posted
50%(1 trials)
Terminated
2(33%)
Phase Distribution
Ph phase_3
1
17%
Ph phase_4
1
17%
Ph phase_2
1
17%
Phase Distribution
0
Early Stage
1
Mid Stage
2
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
2 of 4 finished
Non-Completion Rate
50.0%
2 ended early
Currently Active
1
trials recruiting
Total Trials
6
all time
Status Distribution
Active(1)
Completed(2)
Terminated(2)
Other(1)
Detailed Status
Completed2
Terminated2
Recruiting1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
6
Active
1
Success Rate
50.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (33.3%)
Phase 31 (33.3%)
Phase 41 (33.3%)
Trials by Status
completed233%
recruiting117%
terminated233%
unknown117%
Recent Activity
1 active trials
Showing 5 of 6
recruiting
Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection
NCT04367883
terminatedphase_4
Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT
NCT03686696
completed
ACEI or ARB and COVID-19 Severity and Mortality in US Veterans
NCT04467931
unknownphase_2
The Research of Standard Diagnosis and Treatment for HSPN With Mild Proteinuria in Children
NCT02532790
terminatedphase_3
Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy
NCT00318474
Clinical Trials (6)
Showing 6 of 6 trials
NCT04367883
Influenza Vaccination, ACEI and ARB in the Evolution of SARS-CoV2 Infection
NCT03686696Phase 4
Randomized Evaluation of Beta Blocker and ACEI/ARB Treatment in MINOCA Patients - MINOCA-BAT
NCT04467931
ACEI or ARB and COVID-19 Severity and Mortality in US Veterans
NCT02532790Phase 2
The Research of Standard Diagnosis and Treatment for HSPN With Mild Proteinuria in Children
NCT00318474Phase 3
Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy
NCT02215733
The Use of Angiotensin Receptor Blockers and the Risk of Cancer
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6